CORT: Corcept Therapeutics Incorporated

72.77 USD 0.92 (1.28%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio CORT ha avuto una variazione del 1.28% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 71.55 e ad un massimo di 73.43.

Segui le dinamiche di Corcept Therapeutics Incorporated. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

CORT News

Investing 12:18 Corcept submits new drug application for ovarian cancer treatment
Investing 14:34 Piper Sandler reiterates Overweight rating on Corcept Therapeutics stock
Seeking Alpha 20:33 ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
Investing 00:42 Corcept therapeutics officer Guyer sells $7350 in shares
Seeking Alpha 05:45 Beyond Cushing’s: The Undervalued Potential Of Corcept's Cortisol Modulators
Investing 13:17 Truist reiterates buy rating on Corcept stock, citing diabetes opportunity
Seeking Alpha 19:09 Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary
Investing 20:41 Cortisol modulator improves glucose control in diabetes patients
Seeking Alpha 17:24 IHE: Healthcare Dashboard For June (NYSEARCA:IHE)
Investing 21:06 Corcept reports annual meeting outcomes
Investing 17:14 Corcept May 2025 slides: Revenue target of $900-950M amid pipeline advances
Seeking Alpha 21:37 Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring
Investing 00:49 Corcept Therapeutics director Daniel Swisher sells $155k in stock
Seeking Alpha 08:51 American Century Small Cap Growth Fund Q1 2025 Commentary
Seeking Alpha 05:11 Tracking RenTech’s 13F Portfolio – Q1 2025 Update
Seeking Alpha 14:18 Harbor AlphaEdge Small Cap Earners ETF Q1 2025 Commentary (EBIT)
Benzinga 15:20 Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study - Corcept Therapeutics (NASDAQ:CORT)
Investing 10:12 Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
Investing 00:37 Corcept therapeutics officer Joseph Lyon sells shares worth $390,218
Seeking Alpha 12:00 abrdn U.S. Small Cap Equity Fund Q1 2025 Commentary
Investing 11:33 H.C. Wainwright reaffirms Corcept stock price target after study results
Seeking Alpha 06:36 Voya Small Company Fund Q1 2025 Commentary
Investing 18:02 Meta and Biontech Lead Market Cap Stock Movers on Monday
Investing 15:39 Corcept shares rise on positive Phase 3 trial results

Intervallo Giornaliero

71.55 73.43

Intervallo Annuale

32.39 117.34

Chiusura Precedente: 71.88
Apertura: 71.85

Bid: 72.77
Ask: 73.07

Minimo: 71.55
Massimo: 73.43

Volume: 1.652 K

Variazione giornaliera: 1.28%
Variazione Mensile: -0.72%

Variazione Semestrale: 11.37%
Variazione Annuale: 88.18%

15 luglio, martedì